公司资料
ThermoGenesis 股价、新闻与催化剂
- 股票代码:
- THMO
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股票表现
0.00 USD (-99.00%)
收盘价
最后更新: 2026年8月4日
—
市值
股价为何变动
Current closing-price context is not available for THMO.
公司概览
业务概览
ThermoGenesis was a biotechnology company focused on cell processing, cell banking, and manufacturing systems for regenerative medicine. Its business sat at the intersection of tools, services, and cell-therapy enablement.
所在地与行业分类
ThermoGenesis was headquartered in the United States and listed on NASDAQ. It sat in biotechnology tools and cell-processing infrastructure.
商业模式特征
The company depended on platform adoption, manufacturing workflow demand, and the ability to monetize cell-processing technology. Investors historically watched commercial traction and strategic changes.
生物医药行业定位
ThermoGenesis belongs in the cell-processing infrastructure layer of biotech. It is not a classic drug stock, but it supported the manufacturing ecosystem around regenerative medicine.
未来催化剂
- ThermoGenesis is largely a legacy and closeout story now, with catalysts limited to any strategic or asset-resolution update. The market no longer treats it like a fresh growth name.
近期新闻
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。